ERBB2 and breast cancer: For breast cancer, it was shown that HER2/neu mediated tumour metastasis, and survival prognosis is essentially driven by upregulation of the chemokine receptor CXCR4, a membrane-bound G-protein-coupled receptor (Li et al, 2004).